Global transcriptional profiling of human multiple myeloma cells treated with JQ1 reveals a strong correlation between the genes downregulated by JQ1 and the genes comprising MYC-dependent transcriptional pathways. The gene discussed is MYC; the disease is AL amyloidosis.